Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ladner

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 3, 1999
Polypeptides from phage display. A superior source of in vivo imaging agentsR C Ladner
Trends in Biotechnology|October 1, 1995
Constrained peptides as binding entitiesR C Ladner
Pharmacogenomics|March 21, 2001
Phage display and pharmacogenomicsR C Ladner
Biotechnology & Genetic Engineering Reviews|December 7, 2007
Mapping the epitopes of antibodiesRobert C Ladner
Journal of Industrial Microbiology & Biotechnology|November 4, 2015
Harnessing natural product assembly lines: structure, promiscuity, and engineeringChristopher C Ladner, Gavin J Williams
Current Opinion in Biotechnology|September 12, 2001
Novel frameworks as a source of high-affinity ligandsR C Ladner, A C Ley
Methods in Enzymology|January 1, 1996
Affinity maturation of proteins displayed on surface of M13 bacteriophage as major coat protein fusionsB L Roberts, W Markland, R C Ladner
Molecular Diversity|October 1, 1996
Obtaining a family of high-affinity, high-specificity protein inhibitors of plasmin and plasma kallikreinA C Ley, W Markland, R C Ladner
Methods in Enzymology|January 1, 1996
Selection for protease inhibitors using bacteriophage displayW Markland, B L Roberts, R C Ladner
Biochemistry|June 18, 1996
Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombinW Markland, A C Ley, R C Ladner
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 3, 1999
Polypeptides from phage display. A superior source of in vivo imaging agentsR C Ladner
Trends in Biotechnology|October 1, 1995
Constrained peptides as binding entitiesR C Ladner
Pharmacogenomics|March 21, 2001
Phage display and pharmacogenomicsR C Ladner
Biotechnology & Genetic Engineering Reviews|December 7, 2007
Mapping the epitopes of antibodiesRobert C Ladner
Journal of Industrial Microbiology & Biotechnology|November 4, 2015
Harnessing natural product assembly lines: structure, promiscuity, and engineeringChristopher C Ladner, Gavin J Williams
Current Opinion in Biotechnology|September 12, 2001
Novel frameworks as a source of high-affinity ligandsR C Ladner, A C Ley
Methods in Enzymology|January 1, 1996
Affinity maturation of proteins displayed on surface of M13 bacteriophage as major coat protein fusionsB L Roberts, W Markland, R C Ladner
Molecular Diversity|October 1, 1996
Obtaining a family of high-affinity, high-specificity protein inhibitors of plasmin and plasma kallikreinA C Ley, W Markland, R C Ladner
Methods in Enzymology|January 1, 1996
Selection for protease inhibitors using bacteriophage displayW Markland, B L Roberts, R C Ladner
Biochemistry|June 18, 1996
Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombinW Markland, A C Ley, R C Ladner
Pageof 5